List of Figures:
Figure 2-1: World - Pharmaceutical Market Revenue (in Billion US$), 2001-2005
Figure 2-2: World - Pharmaceutical Market Segment by Geographical Region (%), 2005
Figure 2-3: World - Pharmaceutical Market by Therapeutic Segmentation (%), 2004
Figure 2-4: India - Growth in the Pharmaceutical Industry Market (in Billion US$), 2005-2010F
Figure 3-1: India - Bulk Drugs and Formulations Export Trends (in Rs Crore), 1994-95 to 2003-04
Figure 3-2: India - Bulk Drugs, Formulations & Intermediate Import Trends (in Rs Crore), 1994-95 to 2004-05
Figure 3-3: World - Forecast for Contract Manufacturing and Research Services (in Billion US$), 2005-2009
Figure 3-4: India - R&D Investment in the Pharmaceuticals Industry (in Million US$), 1993-94 to 2000-01
Figure 3-5: India - R&D Expenditure by Company (in Million US$), 2004-05
Figure 3-6: India - Biotechnology Market Composition (%), 2004-05
Figure 5-1: India - Population (in Million), 2001-2005
Figure 5-2: India - Growth in Real GDP (%), 2000-2005
Figure 5-3: India - Real Personal Disposable Income (in Billion US$), 2000-2005
Figure 5-4: India - Per Capita Income (in Rs), 2002-2004
Figure 5-5: India - Urban Population (in Million), 2001-2005
Figure 5-6: India - Growth in Urban Population (%), 2001-2005
Figure 5-7: India - Number of Cardiac Disease Related Treatments (in Million), 2004-2008F
Figure 5-8: India - Rise in % of Population Aged 65 years and above (2000-2005)
Figure 6-1: India - Contract Research Market (in Billion US$), 2004-2008F
Figure 9-1: Cadila Healthcare Ltd. - Stock Performance
Figure 9-2: Cipla Ltd. - Stock Performance
Figure 9-3: Ranbaxy Laboratories Ltd. - Stock Performance
Figure 9-4: Dr. Reddy's Laboratories Ltd. - Stock Performance
Figure 9-5: Nicholas Piramal India Ltd. - Stock Performance
Figure 9-6: Wockhardt Ltd. - Stock Performance
Figure 9-7: GlaxoSmithkline Pharmaceuticals Ltd. - Stock Performance
Figure 9-8: Pfizer Ltd. - Stock Performance
List of Tables:
Table 2-1: India - Pharmaceutical Industry, 2004
Table 2-2: India - Major Therapeutic Segments, 2004
Table 3-1: India - Bulk Drug & Formulations Production (1994-2004)
Table 3-2: India - Pharmaceuticals Market Export (in Rs Crore), 1994-95 to 2003-04
Table 3-3: India - Pharmaceuticals Market Imports (in Rs Crore), 1994-95 to 2004-05
Table 3-4: Contract Manufacturing Deals (in Million US$), 2004
Table 6-1: India - ANDA Filing by Mid-size Companies (FY 2004 to FY 2006)
Table 6-2: India - R&D Agreements with Foreign Partners
Table 9-1: Cadila Healthcare Ltd. - Ratio Analysis (2003-2005)
Table 9-2: Cadila Healthcare Ltd. - Financial Overview, 2005
Table 9-3: Cadila Healthcare Ltd. - Top Management
Table 9-4: Cipla Ltd. - Ratio Analysis (2003-2005)
Table 9-5: Cipla Ltd. - Financial Overview (in US$), 2004-2006
Table 9-6: Cipla Ltd. - Top Management
Table 9-7: Ranbaxy Laboratories Ltd. - Ratio Analysis (2002-2004)
Table 9-8: Ranbaxy Laboratories Ltd. - Financial Overview (in US$), 2003-2005
Table 9-9: Ranbaxy Laboratories Ltd. - Top Management
Table 9-10: Dr. Reddy's Laboratories Ltd. - Financial Overview (2003-2005)
Table 9-11: Dr. Reddy's Laboratories Ltd. - Top Management
Table 9-12: Nicholas Piramal India Ltd. - Ratio Analysis (2003-2005)
Table 9-13: Nicholas Piramal India Ltd. - Financial Overview (in US$), 2004-2006
Table 9-14: Nicholas Piramal India Ltd. - Top Management
Table 9-15: Wockhardt Ltd. - Ratio Analysis (2003 & 2004)
Table 9-16: Wockhardt Ltd. - Financial Overview (in US$), 2003-2005
Table 9-17: Wockhardt Ltd. - Top Management
Table 9-18: GlaxoSmithkline Pharmaceuticals Ltd. - Ratio Analysis (2002-2004)
Table 9-19: GlaxoSmithkline Pharmaceuticals Ltd. - Financial Overview (in US$), 2003-2005
Table 9-20: GlaxoSmithkline Pharmaceuticals Ltd. - Top Management
Table 9-21: Pfizer Ltd. - Key Financial Information (in Lakh Rs), 2004 & 2005
Table 9-22: Pfizer Ltd. - Top Management
